PubMed:22286761
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-114 | Sentence | denotes | YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. |
| TextSentencer_T2 | 115-232 | Sentence | denotes | Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. |
| TextSentencer_T3 | 233-452 | Sentence | denotes | Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. |
| TextSentencer_T4 | 453-799 | Sentence | denotes | We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. |
| TextSentencer_T5 | 800-927 | Sentence | denotes | However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. |
| TextSentencer_T6 | 928-1087 | Sentence | denotes | Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. |
| TextSentencer_T7 | 1088-1277 | Sentence | denotes | We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. |
| TextSentencer_T8 | 1278-1395 | Sentence | denotes | Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. |
| TextSentencer_T9 | 1396-1556 | Sentence | denotes | We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. |
| TextSentencer_T10 | 1557-1703 | Sentence | denotes | These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells. |
| T1 | 0-114 | Sentence | denotes | YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes. |
| T2 | 115-232 | Sentence | denotes | Malignant mesothelioma (MM) shows frequent inactivation of the neurofibromatosis type 2 (NF2) -tumor-suppressor gene. |
| T3 | 233-452 | Sentence | denotes | Recent studies have documented that the Hippo signaling pathway, a downstream cascade of Merlin (a product of NF2), has a key role in organ size control and carcinogenesis by regulating cell proliferation and apoptosis. |
| T4 | 453-799 | Sentence | denotes | We previously reported that MMs show overexpression of Yes-associated protein (YAP) transcriptional coactivator, the main downstream effector of the Hippo signaling pathway, which results from the inactivation of NF2, LATS2 and/or SAV1 genes (the latter two encoding core components of the mammalian Hippo pathway) or amplification of YAP itself. |
| T5 | 800-927 | Sentence | denotes | However, the detailed roles of YAP remain unclear, especially the target genes of YAP that enhance MM cell growth and survival. |
| T6 | 928-1087 | Sentence | denotes | Here, we demonstrated that YAP-knockdown inhibited cell motility, invasion and anchorage-independent growth as well as cell proliferation of MM cells in vitro. |
| T7 | 1088-1277 | Sentence | denotes | We analyzed genes commonly regulated by YAP in three MM cell lines with constitutive YAP-activation, and found that the major subsets of YAP-upregulating genes encode cell cycle regulators. |
| T8 | 1278-1395 | Sentence | denotes | Among them, YAP directly induced the transcription of CCND1 and FOXM1, in cooperation with TEAD transcription factor. |
| T9 | 1396-1556 | Sentence | denotes | We also found that knockdown of CCND1 and FOXM1 suppressed MM cell proliferation, although the inhibitory effects were less evident than those of YAP knockdown. |
| T10 | 1557-1703 | Sentence | denotes | These results indicate that constitutive YAP activation in MM cells promotes cell cycle progression giving more aggressive phenotypes to MM cells. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 1428-1433 | gene:595 | denotes | CCND1 |
| T1 | 1455-1457 | disease:C0345967 | denotes | MM |
| T2 | 1438-1443 | gene:2305 | denotes | FOXM1 |
| T3 | 1455-1457 | disease:C0345967 | denotes | MM |
| R1 | T0 | T1 | associated_with | CCND1,MM |
| R2 | T2 | T3 | associated_with | FOXM1,MM |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 115-137 | HP_0100001 | denotes | Malignant mesothelioma |
| T2 | 178-195 | HP_0001067 | denotes | neurofibromatosis |
| T3 | 210-215 | HP_0002664 | denotes | tumor |
| T4 | 1669-1679 | HP_0000718 | denotes | aggressive |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22286761_1_0 | 115-137 | expanded | denotes | Malignant mesothelioma |
| SS2_22286761_1_0 | 139-141 | abbr | denotes | MM |
| SS1_22286761_1_1 | 178-202 | expanded | denotes | neurofibromatosis type 2 |
| SS2_22286761_1_1 | 204-207 | abbr | denotes | NF2 |
| SS1_22286761_3_0 | 508-530 | expanded | denotes | Yes-associated protein |
| SS2_22286761_3_0 | 532-535 | abbr | denotes | YAP |
| AE1_22286761_1_0 | SS1_22286761_1_0 | SS2_22286761_1_0 | abbreviatedTo | Malignant mesothelioma,MM |
| AE1_22286761_1_1 | SS1_22286761_1_1 | SS2_22286761_1_1 | abbreviatedTo | neurofibromatosis type 2,NF2 |
| AE1_22286761_3_0 | SS1_22286761_3_0 | SS2_22286761_3_0 | abbreviatedTo | Yes-associated protein,YAP |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22286761-3#218#223#gene26524 | 671-676 | gene26524 | denotes | LATS2 |
| 22286761-3#231#235#gene60485 | 684-688 | gene60485 | denotes | SAV1 |
| 22286761-3#28#30#diseaseC1290375 | 481-483 | diseaseC1290375 | denotes | MM |
| 22286761-3#28#30#diseaseC0345967 | 481-483 | diseaseC0345967 | denotes | MM |
| 22286761-3#28#30#diseaseC1290375 | 481-483 | diseaseC1290375 | denotes | MM |
| 22286761-3#28#30#diseaseC0345967 | 481-483 | diseaseC0345967 | denotes | MM |
| 22286761-8#32#37#gene595 | 1428-1433 | gene595 | denotes | CCND1 |
| 22286761-8#42#47#gene2305 | 1438-1443 | gene2305 | denotes | FOXM1 |
| 22286761-8#59#61#diseaseC1290375 | 1455-1457 | diseaseC1290375 | denotes | MM |
| 22286761-8#59#61#diseaseC0345967 | 1455-1457 | diseaseC0345967 | denotes | MM |
| 22286761-8#59#61#diseaseC1290375 | 1455-1457 | diseaseC1290375 | denotes | MM |
| 22286761-8#59#61#diseaseC0345967 | 1455-1457 | diseaseC0345967 | denotes | MM |
| 218#223#gene2652428#30#diseaseC1290375 | 22286761-3#218#223#gene26524 | 22286761-3#28#30#diseaseC1290375 | associated_with | LATS2,MM |
| 218#223#gene2652428#30#diseaseC0345967 | 22286761-3#218#223#gene26524 | 22286761-3#28#30#diseaseC0345967 | associated_with | LATS2,MM |
| 218#223#gene2652428#30#diseaseC1290375 | 22286761-3#218#223#gene26524 | 22286761-3#28#30#diseaseC1290375 | associated_with | LATS2,MM |
| 218#223#gene2652428#30#diseaseC0345967 | 22286761-3#218#223#gene26524 | 22286761-3#28#30#diseaseC0345967 | associated_with | LATS2,MM |
| 231#235#gene6048528#30#diseaseC1290375 | 22286761-3#231#235#gene60485 | 22286761-3#28#30#diseaseC1290375 | associated_with | SAV1,MM |
| 231#235#gene6048528#30#diseaseC0345967 | 22286761-3#231#235#gene60485 | 22286761-3#28#30#diseaseC0345967 | associated_with | SAV1,MM |
| 231#235#gene6048528#30#diseaseC1290375 | 22286761-3#231#235#gene60485 | 22286761-3#28#30#diseaseC1290375 | associated_with | SAV1,MM |
| 231#235#gene6048528#30#diseaseC0345967 | 22286761-3#231#235#gene60485 | 22286761-3#28#30#diseaseC0345967 | associated_with | SAV1,MM |
| 32#37#gene59559#61#diseaseC1290375 | 22286761-8#32#37#gene595 | 22286761-8#59#61#diseaseC1290375 | associated_with | CCND1,MM |
| 32#37#gene59559#61#diseaseC0345967 | 22286761-8#32#37#gene595 | 22286761-8#59#61#diseaseC0345967 | associated_with | CCND1,MM |
| 32#37#gene59559#61#diseaseC1290375 | 22286761-8#32#37#gene595 | 22286761-8#59#61#diseaseC1290375 | associated_with | CCND1,MM |
| 32#37#gene59559#61#diseaseC0345967 | 22286761-8#32#37#gene595 | 22286761-8#59#61#diseaseC0345967 | associated_with | CCND1,MM |
| 42#47#gene230559#61#diseaseC1290375 | 22286761-8#42#47#gene2305 | 22286761-8#59#61#diseaseC1290375 | associated_with | FOXM1,MM |
| 42#47#gene230559#61#diseaseC0345967 | 22286761-8#42#47#gene2305 | 22286761-8#59#61#diseaseC0345967 | associated_with | FOXM1,MM |
| 42#47#gene230559#61#diseaseC1290375 | 22286761-8#42#47#gene2305 | 22286761-8#59#61#diseaseC1290375 | associated_with | FOXM1,MM |
| 42#47#gene230559#61#diseaseC0345967 | 22286761-8#42#47#gene2305 | 22286761-8#59#61#diseaseC0345967 | associated_with | FOXM1,MM |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1101 | 671-676 | gene:26524 | denotes | LATS2 |
| T1102 | 481-483 | disease:C1290375 | denotes | MM |
| T1103 | 684-688 | gene:60485 | denotes | SAV1 |
| R1 | T1101 | T1102 | associated_with | LATS2,MM |
| R2 | T1101 | T1102 | associated_with | LATS2,MM |
| R3 | T1103 | T1102 | associated_with | SAV1,MM |
| R4 | T1103 | T1102 | associated_with | SAV1,MM |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 367-372 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organ |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 367-372 | http://purl.obolibrary.org/obo/UBERON_0000062 | denotes | organ |